CG Share Price
NASDAQ: CGON | Mid Cap | HealthcareCG Stock Performance
CG Share Price Today
As of 19 November 2026, CG Oncology, Inc.'s share price is $80.03. The stock opened at $79.13, compared to its previous close of $79.05. During today's trading session, CG Oncology, Inc.'s share price traded between $77.44 and $82.01, with an average price of $79.73. Over the past 52 weeks, the stock has recorded a high of $91.94 and a low of $37.10. In terms of performance, CG Oncology, Inc.'s share price has risen by 28.55% over the last six months and is up 78.70% on a year-on-year basis.
CG Share Price Chart
CG Quarterly Profit & Loss
All figures in USD
CG Annual Profit & Loss
All figures in USD
CG Balance Sheet
All figures in USD Million
CG Cash Flow
All figures in USD Million
About CG
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
CG Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $63.65 | $80.08 | +23.94% |
Oct 2026 | $70.67 | $64.61 | -8.99% |
Sep 2026 | $75.53 | $70.99 | -10.16% |
Aug 2026 | $71.04 | $79.02 | +11.02% |
Jul 2026 | $70.70 | $71.17 | +0.28% |
Jun 2026 | $61.27 | $70.97 | +14.01% |
May 2026 | $67.63 | $62.26 | -6.80% |
Apr 2026 | $68.22 | $66.80 | -1.46% |
Mar 2026 | $57.69 | $67.79 | +15.41% |
Feb 2026 | $51.97 | $58.74 | +12.99% |
Jan 2026 | $41.41 | $51.98 | +25.14% |
Dec 2025 | $45.11 | $41.54 | -7.25% |